Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hutterer, GC; Pichler, M; Chromecki, TF; Strini, KA; Klatte, T; Pummer, K; Remzi, M; Mannweiler, S; Zigeuner, R.
Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma.
Histopathology. 2013; 63(3):309-315
Doi: 10.1111/his.12163
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Hutterer Georg
-
Pichler Martin
- Co-Autor*innen der Med Uni Graz
-
Chromecki Thomas
-
Mannweiler Sebastian
-
Pummer Karl
-
Strini Karin
-
Zigeuner Richard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Tumour-associated macrophages (TAM) have been reported to be regulators of progression in various human cancers. We evaluated the prognostic relevance of TAM in a large series of patients with papillary renal cell carcinoma (PRCC).
The impact of TAM on cancer-specific survival (CSS) in 177 patients with PRCC was assessed using the Kaplan-Meier method and log-rank test. A multivariate Cox regression analysis was performed with respect to CSS. The presence of TAM was noted in 112 of 177 (63%) tumours and was associated statistically significantly with favourable pathological parameters, including low pathological T stage, node-negative tumours, low tumour grade, absence of vascular invasion and papillary subtype (all P < 0.05), respectively. Five-year CSS probabilities for patients with TAM-positive tumours were 93.5%, compared with 72.5% in patients with TAM-negative tumours, respectively (P < 0.001). Multivariate analysis revealed node-positive tumours, distant metastases and UICC stage (I versus II-IV) as independent predictors of death from PRCC, whereas the presence of TAM was associated independently with favourable outcome (hazard ratio = 0.45, 95% confidence interval 0.24-0.84, P = 0.012).
The presence of TAM was shown independently to reduce the risk of death from cancer by 55%. The presence of TAM should therefore become part of routine pathology reporting in PRCC.
© 2013 John Wiley & Sons Ltd.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Aged, 80 and over -
-
Carcinoma, Renal Cell - mortality
-
Cohort Studies -
-
Female -
-
Humans -
-
Kaplan-Meier Estimate -
-
Kidney Neoplasms - mortality
-
Macrophages - immunology
-
Male -
-
Middle Aged -
-
Multivariate Analysis -
-
Neoplasm Grading -
-
Neoplasm Staging -
-
Prognosis -
-
Proportional Hazards Models -
-
Retrospective Studies -
-
Young Adult -
- Find related publications in this database (Keywords)
-
macrophages
-
papillary renal cell carcinoma
-
prognosis